Now hiring: Company Engagement Manager
Monday, 11 September 2017
Access to Medicine Foundation
The Access to Medicine Foundation is looking for an experienced Company Engagement Manager to manage the relationship between the Foundation and pharmaceutical companies, including facilitating the dissemination of results and discussions of the Foundation’s research programmes.
Period: 1 year, renewable
Salary: Commensurate with experience
Location: Amsterdam, the Netherlands
Starting date: As soon as possible
More about Research at the Foundation
The Access to Medicine Foundation analyses and compares pharmaceutical companies’ policies and practices regarding access to medicine in low- and middle-income countries. We benchmark companies against each other, and identify best practices and progress gaps. Our main research programmes in the next two years are the 2018 Access to Medicine Index and the first Antimicrobial Resistance Benchmark.
The Access to Medicine Index is a biennial evaluation of 20 of the world’s largest research-based pharmaceutical companies. The Antimicrobial Research Benchmark is a new tool that will track how pharmaceutical, generic and biopharmaceutical companies are responding to the global increase in drug-resistance. The Foundation also publishes the first Access to Vaccines Index, and thematic studies focused on priority access topics, such as improving access to cancer care.
About the Access to Medicine Foundation
The Access to Medicine Foundation is an independent non-profit organisation based in Amsterdam. Our mission is to stimulate and guide pharmaceutical companies to do more for the 2 billion people worldwide who cannot access the medicine they need. The core pillar of our work is researching how pharmaceutical companies address the availability, affordability and accessibility of their products in low- and middle-income countries. To turn our research into real-world change, we engage with leading organisations, including companies, NGOs and governments.
About the Role
The Company Engagement Manager will manage the relationship between the Foundation and pharmaceutical companies, with a particular focus on those companies in the scope of our research. The main responsibilities include:
- Developing and implementing an annual company engagement strategy, including definition of deliverables and planning of resources;
- Ensuring the Foundation’s engagement and research insights are steered toward our strategic goals and mission of the Foundation in spurring progress in access to medicine in pharmaceutical companies;
- Coordinating the Foundation’s engagement with companies across the research programmes, from the development of the methodology and the collection of data to the dissemination of findings;
- Managing the Foundation’s everyday communication with companies covered by our research and their industry associations;
- Assisting the Executive Director in her interactions with executive-level leadership at companies; and
- Supporting the Foundation’s research teams in their understanding of companies’ structures, priorities and business models, including how to present research insights in tailored toolkits for companies to work with;
- Collaborating efficiently with the Management Team and other staff members responsible for coordinating the operations of the Foundation and Research programmes;
- Reaching out to new pharmaceutical companies that are relevant for our strategic goals; and
- Speaking and representing the Foundation at industry events, seminars and conferences.
The Company Engagement Manager will report to the Management Team and manage a Researcher with a focus on pharmaceutical companies.
The salary will be commensurate to the experience of the candidate.
Profile and essential skills
- At least 5 years’ work experience with the pharmaceutical industry;
- A relevant postgraduate degree in medical, pharmacy, sciences or economics focused in health-related fields;
- Profound knowledge of the pharmaceutical and vaccine business;
- Familiarity with global health issues;
- Proven experience in diplomacy and relationship building;
- Proven ability to plan and manage projects, account management, resource and budget planning, supervise other people and meet tight deadlines;
- Excellent command of English, both spoken and written;
- Ability to translate research and insights for wider audiences;
- Team player; and
- Willingness and availability to travel frequently and work in different time-zones.
- The ideal candidate can easily relocate to the Amsterdam area or is already located in the Netherlands.
Available to start as soon as possible.
Interested candidates should send a CV and the contact details of two referees to Mireille Deen, email@example.com.
Applications will be reviewed on a rolling basis, and interviews will begin as soon as possible.
About the Access to Medicine Index
The Access to Medicine Index analyses 20 of the world’s largest research-based pharmaceutical companies with products for high-burden diseases in low- and middle-income countries. The Index ranks these companies according to their efforts to improve access to medicine in seven areas of corporate behaviour, including pricing, patents, ethical behaviour and donations. It covers 107 low- and middle-income countries and 50 high-burden diseases, and examines eight types of products, from medicines to vaccines to diagnostics. The Index identifies best practices, highlights where progress is being made, and uncovers where critical action is still required. In this way, the Index provides both an incentive and a guide for pharmaceutical companies to do more to improve access to medicine. It is published every two years by the Access to Medicine Foundation, an independent non-profit organisation.
About the Access to Medicine Foundation
The Access to Medicine Foundation is an independent, non-profit organisation based in the Netherlands. It aims to advance access to medicine in low- and middle-income countries by stimulating and guiding the pharmaceutical industry to play a greater role in improving access to medicine. The Foundation is funded by the Bill & Melinda Gates Foundation, the Dutch Ministry of Foreign Affairs and the UK Department for International Development. For ten years, the Foundation has been building consensus on the role for the pharmaceutical industry in improving access to medicine and vaccines. It published its first benchmark of industry activity in this area in 2008, in the first Access to Medicine Index. The fifth Access to Medicine Index was published in November 2016. In 2017, the Foundation has published the first Access to Vaccines Index, funded by the Dutch National Postcode Lottery, the first analysis of pharma company approaches to cancer care in low and middle-income countries, and will publish the first Antimicrobial Benchmark, funded by the UK and Dutch governments.